These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 36259700)
41. Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study. Lazcano-Ponce E; Salmerón J; González A; Allen-Leigh B; León-Maldonado L; Magis C; Aranda-Flores C; Conde-González C; Portillo-Romero AJ; Yunes-Díaz E; Rivera-Rivera L; Vargas G; Nyitray AG; Giuliano AR Salud Publica Mex; 2018; 60(6):703-712. PubMed ID: 30699275 [TBL] [Abstract][Full Text] [Related]
42. Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women. Hessol NA; Holly EA; Efird JT; Minkoff H; Weber KM; Darragh TM; Burk RD; Strickler HD; Greenblatt RM; Palefsky JM AIDS; 2013 Jul; 27(11):1743-51. PubMed ID: 23803793 [TBL] [Abstract][Full Text] [Related]
43. Human Papillomavirus and Associated Cancers: A Review. Jensen JE; Becker GL; Jackson JB; Rysavy MB Viruses; 2024 Apr; 16(5):. PubMed ID: 38793561 [TBL] [Abstract][Full Text] [Related]
44. The Role of Nursing in Preventing HPV-Related Cancers. Baldwin CM Clin J Oncol Nurs; 2020 Oct; 24(5):471. PubMed ID: 32945790 [TBL] [Abstract][Full Text] [Related]
45. Perianal warts as a risk marker for anal high-risk-human papillomavirus (HPV) detection and HPV-associated diseases. Cerejeira A; Cunha S; Coelho R; Macedo G; Barkoudah E; Azevedo F; Lisboa C J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2613-2619. PubMed ID: 32713086 [TBL] [Abstract][Full Text] [Related]
46. Association of Human Papillomavirus Vaccination With the Incidence of Squamous Cell Carcinomas of the Anus in the US. Berenson AB; Guo F; Chang M JAMA Oncol; 2022 Apr; 8(4):1-3. PubMed ID: 35142803 [TBL] [Abstract][Full Text] [Related]
47. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828 [TBL] [Abstract][Full Text] [Related]
48. HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical Cancer. Leite KRM; Pimenta R; Canavez J; Canavez F; de Souza FR; Vara L; Estivallet C; Camara-Lopes LH Acta Cytol; 2020; 64(5):420-424. PubMed ID: 32235115 [TBL] [Abstract][Full Text] [Related]
49. 9-Valent human papillomavirus vaccine: a review of the clinical development program. Luxembourg A; Moeller E Expert Rev Vaccines; 2017 Nov; 16(11):1119-1139. PubMed ID: 28956458 [TBL] [Abstract][Full Text] [Related]
50. The role of nurses in the prevention of anal cancer in HIV-infected men having sex with men - a focus on papillomavirus vaccination and anal cytology screening. Muñoz-Rodríguez J; Millán-Revilla L AIDS Rev; 2022; 24(4):162-165. PubMed ID: 36580603 [TBL] [Abstract][Full Text] [Related]
51. Anal human papillomavirus infection and its relationship with abnormal anal cytology among MSM with or without HIV infection in Japan. Shiojiri D; Mizushima D; Takano M; Watanabe K; Ando N; Uemura H; Yanagawa Y; Aoki T; Tanuma J; Tsukada K; Teruya K; Kikuchi Y; Gatanaga H; Oka S Sci Rep; 2021 Sep; 11(1):19257. PubMed ID: 34584174 [TBL] [Abstract][Full Text] [Related]
52. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines. Almonte M; Sasieni P; Cuzick J Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657 [TBL] [Abstract][Full Text] [Related]
53. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus. Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077 [TBL] [Abstract][Full Text] [Related]
54. Cervical cancer in Ethiopia: a review of the literature. Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682 [TBL] [Abstract][Full Text] [Related]
55. Human papilloma virus-related premalignant and malignant lesions of the cervix and anogenital tract in immunocompromised women. Wielgos AA; Pietrzak B Ginekol Pol; 2020; 91(1):32-37. PubMed ID: 32039466 [TBL] [Abstract][Full Text] [Related]
56. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015. Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577 [TBL] [Abstract][Full Text] [Related]
57. [Screening for cervical cancer, human papillomavirus (HPV) vaccination]. Schaff Z; Járay B Magy Onkol; 2022 Dec; 66(4):325-330. PubMed ID: 37161827 [TBL] [Abstract][Full Text] [Related]
58. Epidemiology and burden of HPV-related disease. Serrano B; Brotons M; Bosch FX; Bruni L Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():14-26. PubMed ID: 29037457 [TBL] [Abstract][Full Text] [Related]
59. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe. Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298 [TBL] [Abstract][Full Text] [Related]
60. HPV testing and vaccination in Europe. Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]